Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

Research Article September 28 2022
Protein kinase C alpha is a central node for tumorigenic transcriptional networks in human prostate cancer
Cancer Research Communications CRC-22-0170.
Research Article September 28 2022
DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1
Cancer Research Communications CRC-22-0013.
Research Article September 27 2022
Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer
Cancer Research Communications CRC-22-0314.
Research Article September 23 2022
Circulating tumor DNA monitoring reveals molecular progression before radiologic progression in a real-life cohort of advanced Non-Small Cell Lung Cancer patients
Cancer Research Communications CRC-22-0258.
Research Article September 23 2022
Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy
Cancer Research Communications CRC-22-0208.
Research Article September 23 2022
Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity
Cancer Research Communications CRC-22-0172.
Research Article September 16 2022
A Preclinical and Phase 1b Study of Palbociclib Plus Nab-Paclitaxel in Patients With Metastatic Adenocarcinoma of the Pancreas
Cancer Research Communications CRC-22-0072.
Research Article September 14 2022
Remodeling of the tumor microenvironment through PAK4 inhibition sensitizes tumors to immune checkpoint blockade
Cancer Research Communications CRC-21-0133.
Research Article September 12 2022
Diagnostic accuracy of blood-based biomarkers for pancreatic cancer: A systematic review and meta-analysis
Cancer Research Communications CRC-22-0190.
Research Article September 12 2022
Pharmaceutical reactivation of attenuated apoptotic pathways leads to elimination of osimertinib drug tolerant cells
Cancer Research Communications CRC-22-0066.
Research Article September 9 2022
Under-representation of Racial Groups in Genomics Studies of Gastroenteropancreatic Neuroendocrine Neoplasms
Cancer Research Communications CRC-22-0093.
Research Article September 9 2022
Smoking associated down-regulation of FILIP1L enhances lung adenocarcinoma progression through mucin production, inflammation and fibrosis
Cancer Research Communications CRC-22-0233.
Research Article September 8 2022
A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)
Cancer Research Communications CRC-22-0169.
Research Article September 8 2022
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis
Cancer Research Communications CRC-22-0142.
Research Article September 1 2022
Financial Toxicities Persist for Cancer Survivors Irrespective of Current Cancer Status: An Analysis of Medical Expenditure Panel Survey
Cancer Research Communications CRC-22-0166.
Research Article September 1 2022
STAG2 expression is associated with adverse survival outcomes and regulates cell phenotype in muscle-invasive bladder cancer
Cancer Research Communications CRC-22-0155.
Research Article September 1 2022
Drug-gene interaction screens coupled to tumour data analyses identify the most clinically-relevant cancer vulnerabilities driving sensitivity to PARP inhibition
Cancer Research Communications CRC-22-0119.
Research Article August 31 2022
Comprehensive characterization of the multiple myeloma immune microenvironment using integrated scRNA-seq, CyTOF, and CITE-seq analysis
Cancer Research Communications CRC-22-0022.
Research Article August 24 2022
Clinical and Biological Activity of Chemo-immunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium
Cancer Research Communications CRC-22-0147.
Research Article July 11 2022
Dietary Non-starch Polysaccharide Intake and Risk of Colorectal Cancer: Findings from the Singapore Chinese Health Study
Cancer Research Communications crc-22-0153.
Close Modal

or Create an Account

Close Modal
Close Modal